Reliq Health Technologies, Inc. Announces Delay in Filing Annual Audited Financials
Reliq Health Technologies Inc. (RQHTF) announced a delay in filing its annual audited financial statements and management's discussion for FY 2022, impacting the scheduled shareholder update webinar. The Company’s audit has become more complex due to significant growth since FY 2021. Despite this delay, Reliq confirms that no other material information has been undisclosed. The management, led by CEO Dr. Lisa Crossley, reassures shareholders that the final audit steps are in progress and expects the documents to be filed shortly.
- No undisclosed material information affecting shareholders.
- Management is actively working to minimize the filing delay.
- Delay in filing annual audited financial statements.
- Postponed shareholder update webinar due to audit delays.
HAMILTON, Ontario, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that there will be a brief delay by the Company in the filing of its annual audited consolidated financial statements (“Financial Statements”) and management’s discussion and analysis (“MD&A”) for the fiscal year ended June 30, 2022, and related officer certifications (collectively the “Required Documents”). The Company’s Board of Directors and management confirm that they and the Company’s auditors are working diligently to complete the final steps in the audit process and minimize the filing delay as much as possible. The Company confirms that there is no other material information concerning the affairs of the Company that has not been publicly disclosed.
As a result of this delay the Company is postponing the shareholder update webinar originally planned for 6:30am PDT / 9:30am EDT today and will reschedule as soon as the Required Documents are filed.
“The Company’s business has evolved and grown considerably since our FY 2021 audit, and as a result the audit process has been more complex and time-consuming than either Reliq or our auditors had originally anticipated,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “As a result, we are still working on completing the final steps in the audit process but expect to file the Required Documents very shortly. We thank our shareholders for their patience and look forward to reviewing the audited financials and providing a corporate update via webinar as soon as the audit is completed, and the financials are filed.”
About Reliq Health
Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN: A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company Contact
Investor Relations at ir@reliqhealth.com
US Investor Relations Contact
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
FAQ
What caused the delay in Reliq Health Technologies' financial statements filing for FY 2022?
When is Reliq Health Technologies expected to file its financial statements?
What impact does the delay have on shareholders of Reliq Health Technologies?
What is the current status of Reliq Health Technologies' audit process?
